Longevity is often perceived as something to consider later in life.

Biology suggests otherwise. The processes that determine long-term health begin decades before the onset of symptoms.

The question, therefore, is not whether longevity matters, but when it becomes biologically relevant.

Longevity is not about living longer

Longevity is frequently confused with lifespan. Yet the more meaningful metric is healthspan — the period during which physiological systems remain functional, stable and resilient.

While life expectancy has increased significantly over the past century, healthspan has progressed more slowly. In many cases, this has resulted in a prolonged phase of functional decline, often characterized by metabolic dysfunction, reduced mobility, and cognitive decline.

Aging is not an event, but a gradual biological process: an accumulation of cellular and systemic changes that become progressively perceptible. These shifts often emerge as early as the late thirties: slower recovery after exertion, less stable sleep, greater energy variability, increased sensitivity to stress, or biomarkers trending toward the upper limits of “normal” ranges.

From a biological perspective, the challenge is not simply to extend life, but to delay the onset and progression of these imbalances.

First inflection point: metabolic flexibility

One of the first functional changes involves metabolic flexibility — the body's ability to efficiently switch between glucose and lipids as energy sources.

As this flexibility declines, the organism becomes more dependent on a constant glucose supply, which may increase glycemic variability and oxidative stress.

These changes are often silent, yet they gradually shape our metabolic trajectory.

Biomarkers precede symptoms

Several biological markers begin to shift long before any clinical manifestation appears. They do not indicate disease, but rather a direction.

Fasting glucose, inflammatory markers, or homocysteine levels reflect underlying physiological states well before the onset of pathology. They signal a trajectory, not a diagnosis.

It is at this stage that prevention is most relevant. Once symptoms appear, interventions become more corrective than preventive.

What truly makes a difference

Longevity relies on the stability of interconnected systems — glycemic regulation, mitochondrial function, muscle mass, inflammatory balance. When these systems are supported early, their effects compound over time.

Stable glycemic regulation reduces metabolic stress. Adequate micronutrient status supports enzymatic activity and mitochondrial energy production. Managing low-grade inflammation limits progressive tissue damage. Preserving muscle mass help maintain both metabolic and functional resilience.

Also, sleep quality plays a central role in neurocognitive recovery and cellular repair mechanisms.

These are not complex interventions, but rather foundational conditions to sustain over time.  

Key takeaway

Longevity is not defined by age, but by biological trajectory.

For most individuals, the first noticeable shift occurs in mid-life, around 35 to 40, when compensatory mechanisms become less efficient in maintaining balance. This does not mark the beginning of ageing, but rather the point at which it becomes perceptible.

The good news : this trajectory is cumulative, yet can still be modulated. Even when certain imbalances are established, targeted adjustments can positively influence physiological functions and slow their progression.

Consistent, well-calibrated actions, such as physical activity, adequate nutrition and sleep quality, can meaningfully influence long-term health.